drugset / Trial / NCT03878693

4-methylpyrazole and Acetaminophen Metabolism

NCT03878693

Phase 0 Completed 6 enrolled University of Arizona
RandomizedSingle-groupOpen-labelOther

Summary

Oxidative metabolism of APAP will be studied with and without 4-MP.

Timeline

Start
2018-07-01
Primary completion
2018-10-31
Completion
2018-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 80 mg/kg Oral
Subject Fomepizole Small molecule Intravenous

Indications

No indication recorded.